Loading
Senate Finance Committee Chairman Mike Crapo announced a hearing to consider nominations to the U.S. International Trade Commission. USITC commissioners adjudicate antidumping, countervailing duty, safeguard, and Section 337 unfair-import proceedings, making their confirmation directly consequential to US trade-remedy administration.
The hearing was announced June 18, 2026 with the hearing date set for June 25, indicating Chairman Crapo is moving the nominations on an expedited schedule. The size of the nominee slate, five commissioners simultaneously, suggests the Commission has been operating below its statutory complement, creating adjudicatory pressure across active trade-remedy dockets.
Chairman Crapo and the Republican majority on Senate Finance control the hearing calendar and are advancing these nominations, consistent with the broader administration posture of staffing trade-enforcement bodies during an active tariff and trade-remedy cycle. There is no evident cross-pressure from the record, though confirmation of five commissioners at once will require floor time that competes with other legislative priorities.
A fully seated USITC restores the Commission's capacity to issue timely injury determinations in AD/CVD proceedings, which directly affects the pace at which US import duties are imposed on goods from targeted countries; trading partners whose exports face pending petitions have a direct interest in who sits on the Commission and how quickly cases are decided.